These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34594940)

  • 1. Progress of Active Surveillance for Vaccine Safety in China.
    Liu Z; Meng R; Yang Y; Li K; Yin Z; Ren J; Shen C; Feng Z; Zhan S
    China CDC Wkly; 2021 Jul; 3(27):581-583. PubMed ID: 34594940
    [No Abstract]   [Full Text] [Related]  

  • 2. Active Vaccine Safety Surveillance: Global Trends and Challenges in China.
    Liu Z; Meng R; Yang Y; Li K; Yin Z; Ren J; Shen C; Feng Z; Zhan S
    Health Data Sci; 2021; 2021():9851067. PubMed ID: 38487501
    [No Abstract]   [Full Text] [Related]  

  • 3. [Develop the active surveillance system for vaccine safety in China].
    Cai T; Zhan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):664-667. PubMed ID: 31288335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China.
    Liu Z; Zhang L; Yang Y; Meng R; Fang T; Dong Y; Li N; Xu G; Zhan S
    J Med Internet Res; 2020 Jun; 22(6):e17446. PubMed ID: 32234696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scoping review of active surveillance systems for vaccine safety world-wide].
    Cai T; Liu LL; Yao XY; Liu ZK; Yang Y; Meng RR; Zhan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):724-730. PubMed ID: 31288345
    [No Abstract]   [Full Text] [Related]  

  • 6. [Review of near real-time vaccine safety surveillance].
    Sun YX; Liu ZK; Nie XL; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):351-356. PubMed ID: 33626627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety - executive summary.
    Heininger U; Holm K; Caplanusi I; Bailey SR;
    Vaccine; 2017 Jul; 35(32):3917-3921. PubMed ID: 28645716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017.
    Li Z; Xu J; Tan H; Zhang C; Chen J; Ni L; Yun X; Huang Y; Wang W
    Int J Infect Dis; 2020 Oct; 99():149-155. PubMed ID: 32795602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, production, and postmarketing surveillance of hepatitis A vaccines in China.
    Cui F; Liang X; Wang F; Zheng H; Hutin YJ; Yang W
    J Epidemiol; 2014; 24(3):169-77. PubMed ID: 24681843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress on immune efficacy, safety, vaccination intention and immunization strategy of domestic enterovirus 71 vaccine after its marketing].
    Xu WJ; Chen EF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):1010-1016. PubMed ID: 32907294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.
    Kenigsberg TA; Hause AM; McNeil MM; Nelson JC; Ann Shoup J; Goddard K; Lou Y; Hanson KE; Glenn SC; Weintraub ES
    Vaccine; 2022 May; 40(22):3064-3071. PubMed ID: 35428497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance for adverse events following immunization.
    Crawford NW; Clothier H; Hodgson K; Selvaraj G; Easton ML; Buttery JP
    Expert Rev Vaccines; 2014 Feb; 13(2):265-76. PubMed ID: 24350637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.
    Pillsbury AJ; Glover C; Jacoby P; Quinn HE; Fathima P; Cashman P; Leeb A; Blyth CC; Gold MS; Snelling T; Macartney KK
    BMJ Open; 2018 Oct; 8(10):e023263. PubMed ID: 30341132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China.
    Meng R; Ma R; Wang J; Liu P; Liu Z; He B; Liu Z; Yang Y; Zhan S
    Expert Rev Vaccines; 2023; 22(1):696-703. PubMed ID: 37497832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial.
    Gold MS; Lincoln G; Bednarz J; Braunack-Mayer A; Stocks N
    Vaccine; 2021 Jan; 39(2):237-246. PubMed ID: 33309486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.
    Wang Y; Dong D; Cheng G; Zuo S; Liu D; Du X
    Vaccine; 2014 Oct; 32(44):5875-9. PubMed ID: 25173477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.
    Sebastian J; Gurumurthy P; Ravi MD; Ramesh M
    Ther Adv Vaccines Immunother; 2019; 7():2515135519889000. PubMed ID: 31799496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New research progress of the safety of human papillomavirus vaccine].
    Chen W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):428-434. PubMed ID: 33730840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.